KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) Return on Capital Employed: 2018-2025

Historic Return on Capital Employed for Aurinia Pharmaceuticals (AUPH) over the last 7 years, with Sep 2025 value amounting to 0.16%.

  • Aurinia Pharmaceuticals' Return on Capital Employed rose 23.00% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year increase of 23.00%. This contributed to the annual value of -0.01% for FY2024, which is 20.00% up from last year.
  • Latest data reveals that Aurinia Pharmaceuticals reported Return on Capital Employed of 0.16% as of Q3 2025, which was up 30.50% from 0.12% recorded in Q2 2025.
  • Aurinia Pharmaceuticals' 5-year Return on Capital Employed high stood at 0.16% for Q3 2025, and its period low was -0.47% during Q3 2021.
  • For the 3-year period, Aurinia Pharmaceuticals' Return on Capital Employed averaged around -0.08%, with its median value being -0.14% (2024).
  • Per our database at Business Quant, Aurinia Pharmaceuticals' Return on Capital Employed dropped by 20bps in 2021 and then climbed by 26bps in 2025.
  • Over the past 5 years, Aurinia Pharmaceuticals' Return on Capital Employed (Quarterly) stood at -0.44% in 2021, then climbed by 18bps to -0.26% in 2022, then climbed by 6bps to -0.19% in 2023, then grew by 18bps to -0.01% in 2024, then increased by 23bps to 0.16% in 2025.
  • Its Return on Capital Employed was 0.16% in Q3 2025, compared to 0.12% in Q2 2025 and 0.07% in Q1 2025.